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Equações de referência para os testes de caminhada de campo em adultos saudáveis
Victor Zuniga Dourado, Milena Carlos Vidotto, Ricardo Luís Fernandes Guerra
Abstract
Objective: To develop regression equations for predicting six-minute and incremental shuttle walk distances 
(6MWD and ISWD, respectively), based on demographic characteristics, anthropometric variables, and grip 
strength. Methods: We evaluated 6MWD and ISWD in 98 healthy adults. Height, weight, and grip strength were 
also assessed. Using data from 90 of the participants (40 males; 60 ± 9 years of age), we devised linear equations 
adjusted for age, gender, height, and weight, and we developed alternate models that included grip strength. 
We prospectively applied the equations in the 8 remaining participants (4 males; 59 ± 10 years), who had been 
randomly separated from the initial sample. Results: Age, gender, height, and weight collectively explained 54.5% 
and 64.9% of the variance in 6MWD and ISWD, respectively, whereas age, height, weight, and grip strength 
collectively explained 54.4% and 69.0% of the respective variances. There was no significant difference between 
the measured and predicted 6MWD using equations with and without grip strength (14 ± 57 vs. 13 ± 67 m). Similar 
results were observed for ISWD (25 ± 104 vs. 25 ± 93 m). Conclusions: Grip strength is a determinant of ISWD 
and 6MWD; however, it could not improve the power of equations adjusted by demographic and anthropometric 
variables. The validity of our models including grip strength should be further evaluated in patients with skeletal 
muscle dysfunction. 
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Resumo
Objetivo: Desenvolver equações de regressão para a previsão das distâncias caminhadas nos testes de caminhada de 
seis minutos e incremental shuttle walk test (DTC6 e ISWD) baseadas em atributos demográficos, antropométricos 
e força de preensão manual. Métodos: Avaliamos a DTC6 e ISWD em 98 adultos saudáveis. Estatura, peso e 
força de preensão manual foram também avaliados. Equações ajustadas para idade, gênero, estatura e peso e 
equações, incluindo também a força de preensão manual, foram desenvolvidas dos dados de 90 participantes 
(40 homens; 60 ± 9 anos). Aplicamos prospectivamente as equações em 8 participantes (4 homens; 59 ± 10 anos) 
randomicamente selecionados da amostra inicial. Resultados: Idade, gênero, altura e peso explicaram coletivamente 
54,5% e 64,9% da variância da DTC6 e ISWD, respectivamente, ao passo que idade, altura, peso e força de preensão 
manual explicaram coletivamente 54,4% e 69.0% da variância da DTC6 e ISWD, respectivamente. A diferença entre 
a DTC6 prospectivamente avaliada e prevista não foi significativa usando equações com e sem força de preensão 
manual (14 ± 57 m vs. 13 ± 67 m). Resultados semelhantes foram observados para a ISWD (25 ± 104 m vs. 25 ± 
93 m). Conclusões: A força de preensão manual é um determinante para DTC6 e ISWD; entretanto, não foi capaz 
de aumentar o poder das equações ajustadas por variáveis demográficas e antropométricas. A validade de nossos 
modelos incluindo a força de preensão manual deve ser avaliada em pacientes com disfunção muscular esquelética. 
Descritores: Caminhada; Exercício; Valores de referência; Teste de esforço.
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36.6% of the 6MWD variance. Jürgensen et al.
(10) evaluated ISWD in 131 Brazilian individuals. 
Using a predictive model, the authors showed 
that age, height, weight, and gender collectively 
explained 50.3% of the ISWD variance. In 
a recent multicenter study, the predictive 
equations varied widely across centers (adjusted 
R2 = 0.09-0.73) and explained < 30% of the 
6MWD variance at four of the centers evaluated.
(11)
The assessment of grip strength (GS) 
has broad clinical applicability, because it is 
a low-cost, simple, rapid, and noninvasive 
method,(12,13) providing an indicator of general 
health and overall muscle function.(12) Various 
authors have found GC to correlate significantly 
and positively with 6MWD and ISWD, especially 
in patients with COPD.(7,14-16) In healthy elderly 
individuals, GS has been identified as a 
determinant of 6MWD.(7)
The use of faulty reference equations can 
result in mistakes related to the interpretation of 
the level of physical fitness and the improvement 
in walking distance after interventions in patients 
with chronic diseases. Therefore, the purpose of 
this study was to develop regression equations 
for predicting the 6MWD and ISWD, based on 
demographic characteristics, anthropometric 
variables, and GS. We also attempted to 
determine whether GS correlates with ISWD and 
6MWD.
Methods
We evaluated 98 healthy subjects—all over 
40 years of age—some recruited from among 
employees of the Federal University of São 
Paulo, located in the city of Santos, Brazil, 
and others recruited from among residents 
of the surrounding community, through 
newspaper advertisements. Subjects completed 
a questionnaire regarding physical activity, and 
those determined to engage in such activity for 
less than 30 min/day were classified as sedentary.
(17) On the basis of their BMI, the subjects 
were stratified into the following categories: 
underweight (< 18.5 kg/m2); normal weight 
(18.5-24.9 kg/m2); overweight (25-29.9 kg/m2); 
and obese (≥ 30 kg/m2). All of the subjects selected 
for study were healthy and ambulatory (having 
no cardiorespiratory, metabolic, neuromuscular, 
or musculoskeletal disease and requiring no 
walking aids). Subjects with abnormal post-
Introduction
Walking tests, such as the six-minute walk 
test (6MWT) and incremental shuttle walk test 
(ISWT),(1,2) are economically accessible and offer 
the advantage of operational simplicity. These 
tests are well established and have become widely 
used measures of exercise capacity in patients 
with any of a number of chronic diseases.
The 6MWT, which is of a fixed duration, is 
influenced by external factors, such as motivation 
and the amount of effort expended. Therefore, 
the instructions and level of encouragement 
given should be carefully standardized.(1) On the 
6MWT, the pace is determined by the subject, 
and the distance covered therefore varies widely, 
even among healthy individuals.(3-6) However, 
on the ISWT, there is a controlled, progressive 
increase in pace every 60 s.(2) Both tests are safe 
when preformed appropriately and have been 
used, with no adverse effects, in thousands of 
patients with heart or lung disease.(1)
Various demographic, anthropometric, and 
physiological factors can influence the total 
distance covered on field walking tests, such 
as the six-minute walk distance (6MWD) and 
the incremental shuttle walk distance (ISWD). 
Shorter individuals and women have shorter 
strides and consequently cover less distance. 
Elderly and obese individuals often have low 
lean body mass and therefore also cover shorter 
distances. The 6MWD has been reported to be 
below average in unmotivated individuals, those 
with cognitive deficits, and those with arthritis or 
other musculoskeletal disorders.(3,7) Other factors 
that can influence the 6MWD include symptoms 
of depression, impaired health-related quality of 
life, medication use, systemic inflammation, and 
impaired pulmonary function.(7)
To our knowledge, only three studies have 
formulated reference equations to predict the 
6MWD and ISWD in Brazilian individuals.(8-10) 
Iwama et al.,(9) who evaluated 6MWDs in 134 
healthy Brazilians (73 women) ≥ 13 years of age, 
found that age and gender collectively explained 
30.0% of the variance in 6MWD. Priesnitz et al.(8) 
evaluated a convenience sample of 188 healthy 
Brazilian children and adolescents (92 males) 
between 6 and 12 years of age, recruited from 
three elementary schools. The authors found 
that age, height, weight, and absolute difference 
between pre- and post-6MWT HR correlated 
significantly with 6MWD, collectively explaining 
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protocol consists of 12 stages (total distance, 
1,020 m). However, because we were applying 
the test in healthy subjects, we extended it to 
15 stages (1,500 m), in order to avoid the ceiling 
effect. 
The dominant hand was defined as that 
favored in carrying out daily activities. The 
participants were asked about hand preference 
for activities such as writing, eating, and 
carrying objects. We assessed the GS of the 
dominant hand with a Jamar dynamometer 
(TEC, Clifton, NJ, USA), using the method 
described by Mathiowetz et al.(12) Subjects were 
seated with one arm raised parallel to the trunk, 
shoulder in neutral rotation, elbow flexed 90°, 
and forearm in a neutral position. During the 
test, we allowed hyperextension of the wrist up 
to 30° and ulnar deviation up to 15°. We took 
three measurements, 30 s apart. The greatest of 
the three measurements was used in the data 
analysis.
The statistical analysis was performed with 
the Statistical Package for the Social Sciences, 
version 12 (SPSS Inc., Chicago, IL, USA). Data are 
presented as mean and standard deviation or as 
median and interquartile range. We employed the 
Kolmogorov-Smirnov test to evaluate normality 
of data distribution, Pearson’s or Spearman’s 
correlation coefficient to study correlations 
between variables, and unpaired t-test to 
determine intergroup differences in numerical 
data. We also used stepwise multiple linear 
regression analysis to identify the dependent 
variables that were the best predictors of 6MWD 
and ISWD. Age, gender, height, and weight were 
included in the regression models. Alternate 
models were constructed to include GS. Gender 
interaction terms were included for age, height, 
weight, and GS. Correlations between ISWD and 
GS and between 6MWD and GS were determined 
using the z statistic (MedCalc™, version 11.1.1; 
MedCalc Software, Mariakerke, Belgium). Sample 
size was estimated on the basis of the number 
of variables to be entered into the multiple 
regression analysis and the minimum number 
of observations required. The minimum sample 
size was calculated to be at least 50 subjects. 
Multicollinearity in the models was avoided 
by excluding variables with variance inflation 
factors > 4. We evaluated the measured 6MWD 
and ISWD in comparison with the predicted 
bronchodilator lung function were excluded,(18) 
as were those classified as obese. We randomly 
selected 8 individuals—one man and one woman 
from the 40-49, 50-59, 60-69, and ≥ 70 year age 
brackets, respectively—to serve as test subjects, 
and we developed reference equations based on 
data related to the remaining 90 participants. To 
verify the reliability of our reference equations, 
we applied them in the 8 test subjects. The study 
design was approved by the Human Research 
Ethics Committee of the Federal University 
of São Paulo, and all subjects gave written 
informed consent.
Weight and height were measured by standard 
techniques, with the subjects wearing light 
clothing and no shoes. Weight was measured to 
the nearest 0.1 kg with a calibrated scale, and 
height was determined to the nearest 0.5 cm with 
a stadiometer. The BMI was calculated as weight 
in kilograms divided by height in meters squared 
(kg/m2). Pulmonary function and bronchodilator 
reversibility tests were performed using a hand-
held spirometer (Spiropalm; COSMED, Rome, 
Italy), in accordance with American Thoracic 
Society criteria.(18)
The 6MWT and ISWT were each administered 
twice, on alternate days. Before and after 
each test, we assessed HR, blood pressure, 
breathlessness, and leg fatigue. To minimize the 
learning effect, we allowed an interval of at least 
30 min between tests.(1,19) The 6MWT was carried 
out in accordance with American Thoracic 
Society recommendations.(1) The test consisted 
of walking unaided, as fast as possible, for 6 min 
in a corridor 27-30 m in length. Every 60 s, raters 
provided standardized verbal encouragement, 
as follows: “You’re doing well” and “Keep up 
the good work”. The ISWT was carried out with 
the method described by Singh et al.(2) The 
test consisted of walking a 10-m course at a 
progressive pace. Walking speed was controlled 
by a series of sounds indicating the moment the 
subject should change directions around the 
cone. Every 60 s, another sound indicated the 
moment at which the subject should increase 
the pace. When the subject was unable to reach 
the closest cone (i.e. was > 0.5 m from the cone) 
by the time the signal sounded, the rater ended 
the test, which could also be terminated by the 
subject for any reason. Because the ISWT was 
developed to assess functional exercise capacity 
in patients with lung disease, the original 
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The validation sample comprised the 8 test 
subjects (means: age, 59 ± 10 years; height, 
1.65 ± 0.08 m; weight, 74 ± 12 kg; and BMI, 
27 ± 4 kg/m2). For those 8 subjects, the mean 
6MWD was 588 ± 71 m, corresponding to 
102 ± 9% and 102 ± 11% of the predicted 
values calculated with equations including 
and excluding GS, respectively. The difference 
between the measured and predicted 6MWD 
values was not significant, with or without 
GS (13 ± 67 m and 14 ± 57 m, respectively; 
p > 0.05). The mean ISWD was 515 ± 150 m, 
corresponding to 105 ± 15% and 105 ± 18% of 
the predicted values calculated by the equations 
with and without GS, respectively. The difference 
between the measured and predicted ISWD 
distances derived from our equations. The level 
of statistical significance was set at 5%.
Results
The characteristics of the 90 subjects (40 
males) are summarized in Table 1. All of the 
subjects had normal lung function. The age 
distribution of our sample was as follows: 40-49 
years (n = 20); 50-59 years (n = 21); 60-69 years 
(n = 26); and ≥ 70 years (n = 23). Mean BMI 
was within the overweight range (28 ± 3 kg/
m2). Approximately 52% of the subjects were 
classified as sedentary. The GS, 6MWD, and ISWD 
values were greater in males than in females (43 
± 7 vs. 28 ± 5 kg, 641 ± 63 vs. 540 ± 72 m, 
and 600 ± 91 vs. 417 ± 103 m, respectively; p < 
0.001 for all).
The univariate analysis showed that 
6MWD correlated significantly with age (r = 
−0.35), height (r = 0.58), BMI (r = −0.47), 
and GS (Figure 1a), whereas ISWD correlated 
significantly with age, height, and BMI (r = 
−0.36, r = 0.66, and r = −0.48, respectively; 
p < 0.05 for all), as well as with GS (Figure 1b). 
The correlation coefficient for ISWD and GS 
was significant higher than that obtained for 
6MWD and GS (z statistic = 2.05; p = 0.03). Age, 
gender, height, and weight collectively explained 
54.5% and 64.9% of the variance in 6MWD and 
ISWD, respectively (Table 2). In the alternate 
models, age, height, weight, and GS collectively 
explained 54.4% and 69% of the variance in 
6MWD and ISWD, respectively (Table 3). No 
interactions with gender were detected.
Table 1 - General characteristics of the subjects.
Characteristic Mean ± SD
(n = 90)
Age, years 60 ± 9
Weight, kg 69 ± 12
Height, m 1.60 ± 0.09
BMI, kg/m2 26 ± 4
FEV1, %pred 111 ± 13
FVC, %pred 109 ± 11
FEV1/FVC, % 85 ± 6
GS, kg 33 ± 9
1st 6MWD, m 567 ± 75
2nd 6MWD, m 572 ± 83
1st ISWD, m 451 ± 133
2nd ISWD, m 474 ± 131
BMI: body mass index; GS: grip strength; 6MWD: 
six-minute walk distance; ISWD: incremental shuttle walk 
distance.
Table 2 - Predictive model for incremental shuttle and six-minute walk distances in healthy subjects, using 
demographic and anthropometric attributes.
Variable Incremental shuttle walk distance Six-minute walk distance
Partial R2 Coefficient SE p Partial R2 Coefficient SE p
Constant - 34.608 255.310 - - 299.296 185.784 -
Age, years 0.041 −4.384 0.997 < 0.001 0.047 −2.728 0.725 < 0.001
Weight, kg 0.100 −2.949 0.788 < 0.001 0.112 −2.160 0.574 < 0.001
Height, m 0.443 553.336 157.264 < 0.001 0.346 361.731 114.438 0.002
Gender* 0.065 114.387 28.771 < 0.001 0.038 56.386 20.936 0.009
Total R2 = 0.649 Total R2 = 0.543
*Factor gender: men = 1; women = 0.
Reference equations employed in this model:
Incremental shuttle walk distance = 34.608 − (4.384 vs. age) − (2.949 vs. weight) + (553.336 vs. height) + (114.387 vs. 
gender); standard error of the estimate = 79.4 m
Six-minute walk distance = 299.296 − (2.728 vs. age) − (2.160 vs. weight) + (361.731 vs. height) + (56.386 vs. gender); 
standard error of the estimate = 57.7 m.
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muscle mass, and height than do women. The 
negative influence of advanced age on ISWD 
might be explained by the gradual reduction 
in muscle mass, muscle strength, and maximal 
oxygen uptake that typically occurs in parallel 
with aging.(20) Height has a strong influence, 
which might be attributable to the greater stride 
length in taller individuals, stride length being 
a major predictor of gait speed.(21) However, 
findings related to the question of whether body 
weight correlates with 6MWD and ISWD have 
been inconsistent across studies.(5-7) Nevertheless, 
it is likely that, because of its curvilinear nature, 
this correlation has defied detection in linear 
regressions.(7,10,22)
In the present study, the inclusion of GS 
did not improve the power of commonly used 
reference equations based on anthropometric 
and demographic attributes. This could be 
attributed to the great influence that age, 
weight, height, and gender has on GS. However, 
it is possible that the equations including GS 
would be more appropriate for the evaluation 
of patients with muscle depletion. In such cases, 
muscle strength would be considered, and the 
predicted performance on the 6MWT and ISWT 
might more accurately represent the functional 
capacity of the patients. Further studies are 
needed in order to assess the validity of these 
equations in patients who are more debilitated 
and have skeletal muscle dysfunction, such as 
those with lung diseases, especially COPD, cystic 
fibrosis, and bronchiectasis, in which there is 
typically pronounced muscle loss.
We found that GS correlated strongly with 
ISWD and 6MWD, more so with ISWD. Studies 
that have evaluated the validity of these walking 
tests in patients with chronic disease have 
found GS to be significantly correlated with 
6MWD and ISWD.(14,16) Similar results have been 
described in healthy individuals.(4,7) The fact that 
muscle strength and body weight had a greater 
influence on the ISWD than on the 6MWD 
might be attributable to the incremental nature 
of the ISWT, in which the pace is progressively 
increased at each stage. It is likely that individuals 
walk with intensity above the lactate threshold 
during a large portion of the test, which results 
in greater recruitment of glycolytic muscle 
fibers.(23) One study assessed the ventilatory and 
HR variability thresholds in healthy subjects 
performing the ISWT and recognized indices 
values was also not significant, with or without 
GS (25 ± 93 m and 25 ± 104 m, respectively; 
p > 0.05). 
Discussion
To our knowledge, the present study is the 
first to develop GS-based reference equations 
for predicting ISWD and 6MWD in healthy, 
fully ambulatory subjects. We found that GS 
played an important role in predicting 6MWD 
and ISWD in healthy older adults, explaining 
large proportions of the total variances in these 
variables. Although GS correlated strongly with 
6MWD and ISWD, it correlated more significantly 
with ISWD.
In our study, age, gender, weight, and height 
were identified as independent predictors of 
ISWD and 6MWD. These results are quite similar 
to those previously described for older Brazilians 
adults.(9,10) The influence of gender on walking 
distance might be attributable to the fact that 
men have greater absolute muscle strength, 
Figure 1 - Correlation of grip strength with 
six-minute walk distance (a) and incremental shuttle 
walk distance (b).
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recognized as a determinant of cardiorespiratory 
fitness, should be taken into account.
Our results have clinical implications. 
Traditionally, GS has been used in evaluating the 
physical condition of the upper limbs. However, 
more recently, GS has been assessed in various 
clinical situations. For example, Ling et al.
(27) showed that GS was a major predictor of 
all-cause mortality in adults > 85 years of age. 
Al Snih et al.(28) followed a population-based 
sample of 2,488 noninstitutionalized men and 
women ≥ 65 years of age, 507 of whom died 
within the first five years of the study. The authors 
found that GS was strongly correlated with 
mortality. Poorer performance on the timed walk 
test, as well as diabetes mellitus, hypertension, 
and cancer, were also found to be significant 
negative predictors of five-year survival. Previous 
studies have demonstrated a significant positive 
correlation between GS and body cell mass.
(29) Taekema et al.(30) found that lower GS was 
correlated with poorer scores for functional, 
psychological, and social health domains. The 
authors also showed that lower baseline GS was 
predictive of an accelerated decline in cognition 
and in the ability to perform activities of daily 
living. Therefore, the determination of GS could 
be useful for identifying elderly patients at risk 
for such a decline. As an index of general health 
and muscle strength, GS shows promise. Given 
the low cost of dynamometry, it is reasonable 
to include this variable in regression models 
designed to predict the distance covered on 
walking tests.
The main limitation of the present study was 
the use of a convenience sample, which might 
of transition between moderate and intense 
exercise.(24) However, on the 6MWT, the pace 
is controlled by the subject and an aerobic 
steady state is achieved.(25) This suggests that 
the exercise intensity is at or below the lactate 
threshold in most cases, which results in a lower 
demand for glycolytic muscle fiber recruitment.
(23) In agreement with this, Pelegrino et al.(26) 
found the 6MWD to be similar in COPD patients 
with and without lean body mass depletion, 
indicating that skeletal muscle has a limited 
influence on 6MWD. However, during the test, 
the patients with such depletion presented 
significantly greater HR and sensation of leg 
fatigue. Therefore, muscle mass and muscle 
function both seem to have a more consistent 
influence on ISWD than on 6MWD.
Various chronic diseases have systemic 
manifestations. One major manifestation of 
such diseases is peripheral skeletal muscle 
dysfunction. Although reductions in muscle 
mass and strength occur in parallel, the 
correlation between these variables is not 
linear. Therefore, muscle depletion can occur 
even in patients with normal body mass and 
BMI. For example, patients of the same gender 
with the same anthropometric characteristics 
would be expected to cover the same distance 
on field walking tests, after adjustment for 
anthropometric and demographic attributes, 
based on reference equations. However, 
peripheral muscle strength (i.e., the degree 
of muscle depletion) can differ significantly 
between individuals. To predict performance 
on walking tests, muscle strength, widely 
Table 3 - Predictive model for the incremental shuttle and six-minute walk distances in healthy subjects using 
demographic and anthropometric attributes and grip strength.
Variable Incremental shuttle walk distance (m) Six-minute walk distance (m)
Partial R2 Coefficient SE p Partial R2 Coefficient SE p
Constant - −243.867 183.135 - - 109.764 141.888 -
Age, years 0.038 −2.833 0.872 0.002 0.045 −1.794 0.675 0.004
Weight, kg 0.066 −3.259 0.716 < 0.001 0.088 −2.383 0.555 < 0.001
Height, m 0.047 575.101 126.924 < 0.001 0.062 423.110 98.337 < 0.001
Grip strength, kg 0.538 6.321 1.171 < 0.001 0.348 2.422 0.908 0.009
 Total R2 = 0.690 Total R2 = 0.543
*Factor grip strength: men = 1; women = 0.
Reference equations employed in this model:
Incremental shuttle walk distance = −243.867 − (2.833 vs. age) − (3.259 vs. weight) + (575.101 vs. height) + (6.321 vs. 
grip strength); standard error of the estimate = 74.6 m
Six-minute walk distance = 109.764 − (1.794 vs. age) − (2.383 vs. weight) + (423.110 vs. height) + (2.422 vs. grip strength); 
standard error of the estimate = 57.8 m.
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walked on field walking tests.(3-7,10) The GS 
values, in combination with demographic and 
anthropometric attributes, did not increase the R2 
values of the standard equations. This might be 
attributable to the fact that GS was consistently 
correlated with age, height, and weight, or 
there might have been multicollinearity among 
variables in the alternate models, which could 
also explain that finding. However, the variance 
inflation factor values were < 4, indicating 
that there was no such multicollinearity in the 
alternate models.
We conclude that GS is a determinant of 
the total distance covered on the 6MWT and 
ISWT. However, the inclusion of GS did not 
appreciably improve the power to predict 6MWD 
and ISWD in comparison with that of equations 
including only demographic and anthropometric 
attributes. Nevertheless, reference equations 
including muscle function could be useful for 
interpreting the walk performance of patients 
with skeletal muscle dysfunction.
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